Early Urine Alkalinization and N-Acetylcysteine Administration in the Management of Hair Dye (Paraphenylene Diamine) Intoxication
NCT07080190 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2025-07-23
Summary
This study aimed to determine the role of early urine alkalinization and N-acetylcysteine administration for the prevention of renal damage following hair dye intoxication
Conditions
- Urine Alkalinization
- N-Acetylcysteine
- Hair Dye
- Paraphenylene Diamine
- Intoxication
Interventions
- DRUG
-
Early N-Acetylcysteine
Patients received N-acetyl cysteine early (at admission) in the course of treatment of acute hair dye poisoning.
- DRUG
-
Late N-Acetylcysteine
Patients received the standard treatment of N-acetyl cysteine after starting organ affection in the course of treatment of acute hair dye poisoning.
Sponsors & Collaborators
-
South Valley University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients
NCT00780962 ·Status: COMPLETED ·Phase: PHASE2
-
Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
NCT01017796 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury
NCT02701127 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
N-acetylcysteine Plus Deferoxamine for Patients With Hypotension
NCT00870883 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage
NCT00313807 ·Status: WITHDRAWN ·Phase: PHASE2
-
Accelerated HEmodiafiltration in Severe Acute Diquat (AHEAD) Poisoning
NCT07234383 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Impact of Ascorbic Acid in the Prevention of Vancomycin Induced Nephrotoxicty
NCT03921099 ·Status: UNKNOWN ·Phase: PHASE4
-
N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity
NCT00267384 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Perioperative Use of NAC to Prevent AKI in Patients With Pre-existing Moderate Renal Insufficiency Following Cardiac Surgery
NCT05555511 ·Status: UNKNOWN ·Phase: NA
-
N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome
NCT03346681 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
The Acetylcysteine for Contrast-Induced Nephropathy Trial
NCT00736866 ·Status: COMPLETED ·Phase: PHASE3
-
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
NCT00463749 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease
NCT00506506 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
NCT00247507 ·Status: UNKNOWN ·Phase: PHASE4
-
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
NCT03627130 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Acetylcysteine in Creatinine Clearance
NCT00396396 ·Status: UNKNOWN ·Phase: NA
-
Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients
NCT03423810 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy
NCT00492518 ·Status: COMPLETED ·Phase: PHASE4
-
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
NCT01978405 ·Status: UNKNOWN ·Phase: PHASE4
-
Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock?
NCT04589546 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.
NCT00190034 ·Status: SUSPENDED ·Phase: PHASE4
-
Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 Diabetes
NCT03622957 ·Status: UNKNOWN
-
Study of Contrast - Induced Nephropathy After Intravenous Contrast Procedures at Sohag University Hospitals
NCT06965764 ·Status: RECRUITING
-
Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients
NCT00507052 ·Status: UNKNOWN ·Phase: NA